Study to Investigate the Safety, Tolerability, Pharmacokinetics of PF-06305591 in Healthy Male and Female Subjects

NCT01747941 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PF-06305591
DRUG: Placebo
DRUG: PF-06305591
DRUG: Placebo
DRUG: PF-06305591
DRUG: Placebo

Sponsor

Pfizer